AWSHX
Price
$68.83
Change
+$0.27 (+0.39%)
Updated
Jun 2 closing price
Net Assets
214.46B
MCLVX
Price
$31.89
Change
+$0.28 (+0.89%)
Updated
Jun 2 closing price
Net Assets
804.36M
Interact to see
Advertisement

AWSHX vs MCLVX

Header iconAWSHX vs MCLVX Comparison
Open Charts AWSHX vs MCLVXBanner chart's image
AWSHX vs MCLVX Comparison Chart in %
View a ticker or compare two or three
VS
AWSHX vs. MCLVX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AWSHX is a Hold and MCLVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AWSHX has more cash in the bank: 214B vs. MCLVX (804M). AWSHX pays higher dividends than MCLVX: AWSHX (1.19) vs MCLVX (0.43). AWSHX was incepted earlier than MCLVX: AWSHX (74 years) vs MCLVX (26 years). MCLVX (1.75) is less costly to investors than AWSHX (0.55). MCLVX is a more actively managed with annual turnover of: 120.00 vs. AWSHX (29.00). AWSHX has a lower initial minimum investment than MCLVX: AWSHX (250) vs MCLVX (1000). MCLVX annual gain was more profitable for investors over the last year : 19.38 vs. AWSHX (7.86). AWSHX return over 5 years is better than : 25.50 vs. MCLVX (2.80).
AWSHXMCLVXAWSHX / MCLVX
Total Expense Ratio0.551.5436%
Annual Report Gross Expense Ratio0.551.7531%
Fund Existence74 years26 years-
Gain YTD5.47114.23938%
Front Load6%N/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets214B804M26,617%
Annual Yield % from dividends1.190.43275%
Returns for 1 year7.8619.3841%
Returns for 3 years32.1533.6895%
Returns for 5 years25.502.80912%
Returns for 10 years83.4363.23132%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JVAAX38.42N/A
N/A
JPMorgan Value Advantage A
PCVAX13.00N/A
N/A
Virtus NFJ Small-Cap Value A
RTSAX46.98N/A
N/A
Russell Inv Tax-Managed US Mid&Sm Cap A
MDOAX12.52N/A
N/A
Morgan Stanley Developing Opportunity A
ERHSX13.49N/A
N/A
Eaton Vance Worldwide Health Sci R